Luven Diagnostic

Luven Diagnostic

ICO Ended
14,769 Views
The LUVEN screening test method created by scientist of our company detects cancer at its early stages with the accuracy of up to 96% only comparable to biopsy. None of the existing diagnostic techniques has such a high diagnostic accuracy. The LUVEN technology allows diagnosing the disease at its early stages , thus, giving a chance to thousands of people to prevent its further development.
5.6
TOTAL SCORE
6.5
ICO PROFILE

(weight: 45%)

1
TEAM PROOF

(weight: 20%)

Get widget
General
Website: Visit
White paper: Read
Pre-sale Time: 08 Dec 2017 - 29 Dec 2017
ICO Time: 15 Jan 2018 - 28 Feb 2018
Country: Ukraine
Token info
Ticker: LVN
Platform: Ethereum
Token Type: ERC20
Available for sale: 30,000,000 LVN
Financial
ICO Price: 290 LVN = 1 ETH
Accepting: ETH, BTC
1983
Development ofthe cancer diagnostic method started, based on the study of buccal cells (cells from the inside ofthe cheek)
2004
A cytomorphobiologial diagnostic method appeared which formed the basis ofthe diagnostic complex<br />
2010
Team expansion. A commercial enterprise promoting the LUVEN trademark was established. The software automating a part ofthe diagnostic procedure was created.
2014
The diagnostic method was patented, completion of the clinicaltrials, creation ofthe software diagnostic complex presented at two international medical exhibitions “The 5th International Medical Forum” and “Health Care 2014”. Opening first franchise outlets.
2015
In five months after launching a franchise, the contracts were signed with more than twenty outlets, half of which have already run tests on more than two thousand patients. Suspension of activities for a time allowing technology enhancement.
2016 - 2017
Software enhancement, additional clinicaltrials. Optimizing a big number ofthe system algorithms
September - October 2017
Preparing and starting a preICO aimed at fundraising for the software enhancement, legal costs and operational expenses ofthe project
January 2018
Starting an ICO
2018
Further software enhancement, signing contracts with clinics worldwide for conducting clinicaltrials, opening a research center in Austria. Initiating certification ofthe method in the European Union and Eurasian Union
2019
Opening 20 new labs in the European Union and Eurasian Union, incorporating a blockchain and developing a domestic exchange for token sale, working on the optical recognition of incoming images ofthe cell, creating a database of patients and their test results for monitoring tendencies and informing patients on the necessity of being diagnosed
2020
Starting clinicaltrials and certification in the USA and Asia
2021
Developing home gadgets (a home lab) for running tests on the entire family at any time, launching the product.
Screenshots taken on 5 Feb 2018
Alexander Danilchenko
CEO
No participating data
Nikolay Shchukin
Postgraduate Student of Chair for Biomedical Engineering
No participating data
Aleksander Shchukin
Nuclear Physician
No participating data
Galina Shchukina
Geneticist & Cytologist
No participating data
Grigory Evglevskiy
CTO
No participating data
Alexander Kamensky
Principal Software Engineer
No participating data
Yana Ivchenko
PR Manager
No participating data

Advisors (0)

HEIGHT - 0px
WIDTH - 0px
PUT THIS CODE TO YOUR WEBSITE
ICO List
Other Interesting ICOs
Upcoming
Orion Protocol
ORION is a new kind of blockchain investment platform that combines the best features of exchanges, brokerages, and instant trading apps. The platform is built around a liquidity aggregator connected to all of the major crypto exchanges, as well as its own internal decentralized exchange, enabling users to gain the best price for their trades from a single portal. Along with powerful tools for portfolio management, ORION offers exceptional security, convenience, and flexibility. The platform is suitable for experienced traders, institutional investors, and newcomers alike.
Upcoming
Xsure
Xsure is a decentralized risk management platform that facilitates real-time communication between insurance providers and the end customer. With the help of machine learning and blockchain trust-less governance technologies we have managed to eliminate third parties from the whole insurance life-cycle and turn it into a dynamic process instead of a static one.
Upcoming
Libra Credit
CRED, formerly Libra Credit, is a decentralized lending ecosystem that facilitates open access to credit anywhere and anytime based on the Ethereum blockchain.
Upcoming
Fan360
The first sports community for fans, that covers the complete fan experience. Follow your favourite sports star, club or brand and get rewarded for engaging.
Active
KardiaChain
KardiaChain is the blockchain of blockchains. A scalable and interoperable blockchain platform for decentralized applications. Our Vision: We believe Blockchain can create equal opportunities for people, a world where people have access to opportunity to invest, to start a business, to work and to be socially mobile. Our technology empowers mass adoption, expand use-cases and lay foundation of the blockchain ecosystem. We are building a blockchain platform for decentralised applications helping to create a blockchain ecosystem that allows for scaling and connecting disparate blockchains. Our Core Technology is: - Dual Node - Elastic Sharding With Incentive Mechanism (ESWIM) - Kardia Smart Contract Markup Language (KSML) Our Use cases are: - Supply Chain Management - Fully Decentralised Cross-chain Exchange - Smart City
Upcoming
INVERSE
INVERSE is a DeFi based platform that provides an array of smart-contract features with integrated time-based options. Users have the opportunity to speculate on the drop in value of a suite of Defi coins by utilizing the multiple 'tracking vaults' on the platform. XIV, the protocol's native token, is used to unlock these vaults, and then staked within these vaults for no more than 7 days. As their name implies, these vaults track the real-time price movements of select DeFi tokens (i.e. COMP, AAVE, UNI, YFI). After 7 days, if the value of the DeFi asset being tracked has dropped by a certain percentage, the user will gain a significant percentage yield on the amount of XIV held within the tracking vault. If the price of the DeFi asset does not drop in value beyond the predetermined percentage by the end of the 7-day staking period, the user will forfeit a portion of their staked XIV. Rewards will be automatically disbursed to the user’s web3 browser wallet at the end of the 7-day staking period. Ultimately, INVERSE offers users the option to hedge against the volatility of select crypto assets.